SickleFit Exercise and Nutrition Study
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT07442851
- Status
- Recruiting
Conditions
- Aging
- Sickle Cell Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SickleFit Exercise plus Nutrition — BEHAVIORALSickleFit personalized exercise plus dietitian-facilitated nutrition intervention
Study Details
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
Key Dates
- Start date
- Apr 8, 2026
- Status verified
- May 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: SickleFit armParticipants in SickleFit arm will complete the Sickle Cell Disease Functional Assessment before and after 12 weeks of SickleFit exeercise+Nutrition intervention.
- No Intervention: Control ArmParticipants in the control arm will be on a wait list for SickleFit and will continue to receive usual care during that 12-week period. They will complete the Sickle Cell Disease Functional Assessment at baseline and after 12 weeks on the wait list. After their post-assessment, they will have the option to complete 12 weeks of SickleFit exercise+Nutrition intervention.
Primary Outcome Measure
Feasibility of Randomization [ Time Frame: From enrollment to the last paticipants randomized over a 2 year period ]
Central Contacts
- Teagan Callaway919-684-0628
- Rania Mohamed
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University | Durham | North Carolina | 27710 | Rania Mohamed Charity I Oyedeji, MD (PRINCIPAL_INVESTIGATOR) John J Strouse, MD PhD (SUB_INVESTIGATOR) Kathryn Starr, PhD (SUB_INVESTIGATOR) |
Find similar trials in Durham, NC
By condition
By research site
Related Studies
- Sickle Cell Clinical Research and Intervention ProgramRecruiting · St. Jude Children's Research Hospital · Peoria, Illinois
- Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell DiseasePHASE2 · Recruiting · Robert Nickel · Washington D.C., District of Columbia
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- A Long-term Follow-up Study in Participants Who Received CTX001PHASE3 · Enrolling By Invitation · Vertex Pharmaceuticals Incorporated · Palo Alto, California